Reason: CGMP Deviations: Potential for cross contamination due to product carry over.
Distributed: Nationwide in the USAReason: CGMP Deviations: Potential for cross contamination due to product carry over.
Distributed: Nationwide in the USAReason: Failed Tablet/Capsule Specifications: Tablets exceeds specification for weight and thickness.
Distributed: Nationwide in the USAReason: Lack of assurance of sterility: Bags have the potential to leak in the flexible containers which may compromise sterility.
Distributed: Nationwide in the USAReason: Failed Impurities/Degradation Specifications
Distributed: Nationwide within the United StatesReason: Subpotent Drug: The batches contain less than 90% of the labeled amount of latanoprost.
Distributed: Nationwide in the USAReason: Failed Stability Specifications
Distributed: Within the U.S Market - PA, AL, KY, TNReason: Presence of Particulate Matter: Product complaint for the presence of glass particles in a syringe.
Distributed: Nationwide in the USAReason: Lack of Assurance of Sterility: FDA inspection found the recalled products were produced in a manner than cannot guarantee the sterility of the products purported to be sterile.
Distributed: AL, LA, MS, and TNReason: Lack of Assurance of Sterility: FDA inspection found the recalled products were produced in a manner than cannot guarantee the sterility of the products purported to be sterile.
Distributed: AL, LA, MS, and TN